| 摘要 |
PROBLEM TO BE SOLVED: To provide a combination agent containing an mTOR inhibitor and at least one kind of a pharmaceutical activator; a pharmaceutical composition containing the combination agent; a treatment method including the combination agent; a method for producing the combination agent, and a package for sales, containing the combination agent.SOLUTION: The combination agent is a combination agent of mTOR inhibiting compound and at least one kind of a pharmaceutical activator, for concurrent use, combined use, individual use, or sequential use for prevention or treatment of proliferative diseases. |
